1. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer
   Fujin Fang et al, 2023, PeerJ CrossRef
2. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine
   Simeng Zhang et al, 2022, EPMA Journal CrossRef
3. Hexokinases II‐mediated glycolysis governs susceptibility to crizotinib in ALK‐positive non‐small cell lung cancer
   Caiyu Lin et al, 2021, Thoracic Cancer CrossRef
4. A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
   Jiaqi Su et al, 2022, Frontiers in Oncology CrossRef
5. TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer
   Yung-Fu Chang et al, 2023, Current Issues in Molecular Biology CrossRef
6. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent
   Xilin Zhang et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
7. Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses
   Si-Tong Fan et al, 2023, PLOS ONE CrossRef